300 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
effective on April 1, 2024. J-codes simplify and streamline the billing and reimbursement processes for Medicare Part B treatments, allowing … ; the availability and extent of reimbursement of Regeneron’s Products from third-party payers, including private payer healthcare and insurance programs, health
8-K
EX-99.1
qpswj80vxx0kxiyok
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
EX-99.1
c03ywk2 0b
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
2k5i l4saecaruc4gtm
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T
EX-99
2437s rimfupm
25 Aug 23
Third party tender offer statement
7:46am
8-K
EX-99.1
qi4bmytc rw80ek
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
shxm4vza4idw
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
8-K
EX-10.3
vku20kl3outspkgn30
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
yyfnkgrh0h33gkj wo72
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
iqzpprmda9p
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
orx4l1cg
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm